title: Does therapy targeting normal SBP of less than 120 mm Hg reduce major CV events in T2DM patients?
authors: Joslin Diabetes Center, 1 Joslin Place, Boston, MA, 02215, USA. bijan.roshan@joslin.harvard.edu
authors: Bijan
authors: B
authors: Roshan
references: Nat Clin Pract Nephrol. 2007 Aug;3(8):428-38
references: 17653121
references: Lancet. 1998 Jun 13;351(9118):1755-62
references: 9635947
references: N Engl J Med. 2010 Jul 15;363(3):233-44
references: 20587587
references: N Engl J Med. 2008 Jun 12;358(24):2545-59
references: 18539917
references: Lancet. 2002 Dec 14;360(9349):1903-13
references: 12493255
references: JAMA. 2003 May 21;289(19):2560-72
references: 12748199
references: BMJ. 1998 Sep 12;317(7160):703-13
references: 9732337